Results 181 to 190 of about 3,775 (204)

Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3)

Molecular Cell, 2018
Wei Lin, Kalyan Das, David Degen
exaly  

The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin

Journal of Infection and Chemotherapy, 2020
Tetsuo Yamaguchi, Kotaro Aoki, Yoshikazu Ishii   +2 more
exaly  

Fidaxomicin/warfarin interactions

Reactions Weekly, 2021
openaire   +1 more source

Fidaxomicin/metronidazole/vancomycin

Reactions Weekly, 2023
openaire   +1 more source

Hypersensitivity Reactions Associated With Fidaxomicin Use

Clinical Infectious Diseases, 2014
Sumathi Nambiar, Nambiar Sumathi
exaly  

Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection

Canadian Journal of Infectious Diseases and Medical Microbiology, 2015
James A Karlowsky
exaly  

Fidaxomicin

Reactions Weekly, 2017
openaire   +1 more source

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies

Open Forum Infectious Diseases, 2014
Larry H Danziger, Dale N Gerding, Stuart Johnson   +2 more
exaly  

Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE)

Clinical Infectious Diseases, 2020
Joshua Wolf, Claudia Fortuny, Samantha Bosis   +2 more
exaly  

Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB

Journal of Antimicrobial Chemotherapy, 2018
Julian Schwanbeck, Thomas Riedel, Isabel Schöber   +2 more
exaly